Literature DB >> 3975900

Biodisposition of [3H]diisopropylfluorophosphate in mice.

B R Martin.   

Abstract

The disposition of [3H]diisopropylfluorophosphate (DFP) and its metabolites was studied in mice after iv treatment. In addition, disposition of [3H]DFP in selected tissues was correlated with cholinesterase activity and spontaneous activity following DFP treatment. Within 1 min of administration [3H]DFP had penetrated tissues and was already irreversibly bound. The tissue concentrations of [3H]DFP declined in a rapid fashion so that after 2 hr all concentrations were below 50 pg/mg tissue. The major portion of radioactivity was bound to tissue in the form of [3H]diisopropylphosphoric acid (DIP). There was a decline in [3H]DIP with time in all tissues except liver, kidneys, and fat, which reached a maximum at 30 min before declining. The only appreciable quantities of [3H]DIP remaining after 3 days were in liver and kidneys. There was also evidence that [3H]DFP was rapidly hydrolyzed to free [3H]DIP which was found in all tissues within 1 min of [3H]DFP administration. [3H]DIP concentrations were equivalent to or exceeded those of [3H]DFP in all tissues, except brain. Cholinesterase inhibition in plasma, diaphragm, and brain following DFP treatment (1 mg/kg, iv) was temporarily correlated with the concentrations of bound [3H]DIP in these same tissues between 1 hr and 3 days. Cholinesterase inhibition in brain and diaphragm did not correlate well with bound [3H]DIP at earlier time points which suggested the presence of noncholinesterase binding. DFP treatment (1 mg/kg) also induced motor hypoactivity which lasted up to 6 hr after iv injection. The time course of motor hypoactivity was not correlated with free [3H]DFP, bound [3H]DIP concentrations in the brain, or with cholinesterase inhibition in the brain, which suggested that noncholinesterase bound [3H]DIP was responsible for this CNS depression.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3975900     DOI: 10.1016/0041-008x(85)90327-8

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  5 in total

Review 1.  Positron emission tomography studies of organophosphate chemical threats and oxime countermeasures.

Authors:  Charles M Thompson; John M Gerdes; Henry F VanBrocklin
Journal:  Neurobiol Dis       Date:  2019-04-22       Impact factor: 5.996

2.  Proceedings of the British Pharmacological Society. 9th-11th September 1985. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1985-12       Impact factor: 8.739

3.  Protein binding of isofluorophate in vivo after coexposure to multiple chemicals.

Authors:  John S Vogel; Garrett A Keating; Bruce A Buchholz
Journal:  Environ Health Perspect       Date:  2002-12       Impact factor: 9.031

4.  Physiologically based pharmacokinetic model for the inhibition of acetylcholinesterase by organophosphate esters.

Authors:  J M Gearhart; G W Jepson; H J Clewell; M E Andersen; R B Conolly
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

5.  Allopregnanolone and perampanel as adjuncts to midazolam for treating diisopropylfluorophosphate-induced status epilepticus in rats.

Authors:  Ashish Dhir; Donald A Bruun; Michelle Guignet; Yi-Hua Tsai; Eduardo González; Jonas Calsbeek; Joan Vu; Naomi Saito; Daniel J Tancredi; Danielle J Harvey; Pamela J Lein; Michael A Rogawski
Journal:  Ann N Y Acad Sci       Date:  2020-09-11       Impact factor: 5.691

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.